No. Barrels of API (active pharmaceutical ingredient) are mostly hauled from India or China, then formulated into pills or whatever, this goes especially for generic medicines. There is some american manufacture of APIs, but these tend to be on more expensive side (biologicals or small molecule drugs under patent). Inputs for these APIs also tend to be made in India or China
there shouldn’t be billion dollar startups